Sleep impairment in ecstasy/polydrug and cannabis-only users

American Journal on Addictions

Volumn 18, Issue 5, 2009, Pages 430-437

  Fisk, John E ^a   Montgomery, Catharine ^b  

^a UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

^b LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANNABIS ADDICTION; CIRCADIAN RHYTHM; CLINICAL ASSESSMENT; CLINICAL INDICATOR; DAYTIME SOMNOLENCE; DISEASE ASSOCIATION; EPWORTH SLEEPINESS SCALE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE DRUG ABUSE; QUESTIONNAIRE; SELF REPORT; SLEEP DISORDER; SLEEP PATTERN; SLEEP TIME;

AMPHETAMINE; COCAINE; COGNITION; FEMALE; HUMANS; MALE; MARIJUANA SMOKING; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PSYCHOMOTOR PERFORMANCE; SLEEP INITIATION AND MAINTENANCE DISORDERS; YOUNG ADULT;

EID: 71049150089     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1080/10550490903077762     Document Type: Article

References (31)

1. Carhart-Harris RL, Nutt DJ, Munafo M, Wilson SJ. Current and former ecstasy users report different sleep to matched controls: a web-based questionnaire study. [published online ahead of print June 18, 2008]. J Psychopharmacol. 2009;23:249-257. doi:10.1177/0269881108089599.
2. Baylen CA Rosenberg H. A review of the acute subjective effects of MDMA/ecstasy. Addiction. 2006;101:933-947.
3. Huxster JK, Pirona A, Morgan MJ. The sub-acute effects of recreational ecstasy (MDMA) use: a controlled study in humans. J Psychopharmacol. 2006;20: 281-290.
4. Montoya AG, Sorrentino R, Lukas SE, Price BH. Long-term neuropsychiatric consequences of "ecstasy" (MDMA): A review. Harvard Rev Psychiatry. 2002;10:212-220.
5. Schierenbeck T, Riemann D, Berger M, Hornyak M. Effect of illicit recreational drugs upon sleep: Cocaine, ecstasy and marijuana. Sleep Medicine Reviews. 2008;12:381-389.
6. Dughiero G, Schifano F, Forza G. Personality dimensions and psychopathological profile of Ecstasy users. Hum Psychopharmacol. 2001;16:635-639.
7. Soar K, Parrott AC, Fox HC. Persistent neuropsychological problems after 7 years of abstinence from recreational ecstasy (MDMA): A case study. Psycholog Rep. 2004;95:192-196.
8. Parrott AC, Rodgers J, Buchanan T, Ling J, Heffernan T, Scholey AB. Dancing hot on ecstasy: physical activity and thermal comfort ratings are associated with the memory and other psychobiological problems reported by recreationalMDMAusers. Human Psychopharmacology Clin Exp. 2006;21:285-298.
9. Allen R, McCann UD, Ricaurte GA. Persistent Effects of (+)3,4- Methylenedioxymethamphetamine (MDMA, "Ecstasy") on Human Sleep. Sleep. 1993;16:560-564.
10. McCann UD, Ricaurte GA. On the neurotoxicity of MDMA and related amphetamine derivatives. J Clin Psychopharmacol. 1995;15:295-296.
11. Insel TR, Battaglia G, Johannessen JN, Marra S. 3,4- Methylenedioxymethamphetamine ("Ecstasy") selectively destroys brain serotonin terminals in rhesus monkeys. Journal of Pharmacology and Experimental Therapeutics. 1989;249:713-720.
12. Balogh B, Molnar E, Jakus R, et al. Effects of a single dose of 3,4- methylenedioxymethamphetamine on circadian patterns, motor activity and sleep in drug-naive rats and rats previously exposed to MDMA. Psychopharmacology. 2004;173:296-309.
13. SantucciV, Storme J-J, Soubríe P, Le Fur G. Arousal-enhancing properties of the CB1 cannabinoid receptor antagonist SR 14176A in rats as assessed by electroencephalographic spectral and sleep-waking cycle analysis. Life Sciences. 1996;58:PL103-PL110. (Pubitemid 26037221)
14. Tassinari CA, Ambrosetto G, Peraita-Adrado MR, Gastaut H. The neuropsychiatric syndrome of--9-tetrahydrocannabinol and cannabis intoxication in naive subjects: A clinical and polygraphic study during wakefulness and sleep. In: Nahas GG, Sutin KM, Harvey D, Agurell S, Pace N. Marihuana and medicine. Totowa, NJ: Humana Press; 1999:649-664.
15. Nicholson AN, Turner C, Stone BM, Robson PJ. Effect of - 9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults. J Clin Psychopharmacol. 2004;24:305-313.
16. Budney AJ, Moore BA, Vandrey RG, Hughes JR. The time course and significance of cannabis withdrawal. J Abnorm Psychol. 2003;112:393-402.
17. Arendt M, Rosenberg R, Foldager L, Sher L, Munk-Jorgensen P. Withdrawal symptoms do not predict relapse among subjects treated for cannabis dependence. Am J Addict. 2007;16:461-467.
18. Montgomery C, Fisk JE, Wareing M, Murphy PN. Self reported sleep quality and cognitive performance in ecstasy users. Hum Psychopharmacol. 2007;22:537-548.
19. Johns M, Hocking B. Daytime sleepiness and sleep habits of Australian workers. Sleep. 1997;20:844-849.
20. GillbergM,Kecklund G, Akerstedt T.Relations between performance and subjective ratings of sleepiness during a night awake. Sleep. 1994;17:236-241.
21. Smith CS, Reilly C, Midkiff K. Evaluation of three circadian rhythm questionnaires with suggestions for an improvedmeasure ofmorningness. J Appl Psychol. 1989;74:728-738
22. Biello SM, Dafters RI. MDMA and fenfluramine alter the response of the circadian clock to a serotonin agonist in vitro. Brain Research. 2001;920:202-209.
23. Colbron S, Jones M, Biello SM. MDMA alters the response of the circadian clock to a photic and non-photic stimulus. Brain Research. 2002;956:45-52.
24. Parrott AC, Sisk E, Turner JJD. Psychobiological problems in heavy "ecstasy" (MDMA) polydrug users. Drug Alcohol Depend. 2000;60:105-110.
25. Topp L, Hando J, Dillon P, Roche A, Solowij N. Ecstasy use in Australia: patterns of use and associated harm. Drug Alcohol Depend. 1999;55:105-115
26. Cole JC, Sumnall HR. Altered states: the clinical effects of Ecstasy. Pharmacol Ther. 2003;98:35-58.
27. Fox HC, McLean A, Turner JJD, Parrott AC, Rogers R, Sahakian BJ. Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users. Psychopharmacology. 2002;162:203-214.
28. Morgan MJ. Recreational use of "ecstasy" (MDMA) is associated with elevated impulsivity. Neuropsychopharmacology. 1998;19:252-264.
29. Morgan MJ.Memory deficits associated with recreational use of "ecstasy" (MDMA). Psychopharmacology. 1999;141:30-36.
30. Rodgers J. Cognitive performance amongst recreational users of "ecstasy." Psychopharmacology. 2000;151:19-24.
31. Horne JA, Ostberg O. Self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms. Int J Chronobiol. 1976;4:97-110.